Bethesda, Maryland, United States We can highlight the next thriving fund investment areas, such as Medical, Non Profit. Among the most popular portfolio startups of the fund, we may highlight Peptide Logic.
Deals in the range of 50 - 100 millions dollars are the general things for fund. The fund is generally included in 2-6 deals every year. The top activity for fund was in 2019.
The standard case for the fund is to invest in rounds with 1 partaker. Despite the National Institute on Drug Abuse (NIDA), startups are often financed by National Institutes of Health.
Related Funds
| Fund Name | Location |
| 2b AHEAD Ventures | Germany, Leipzig, Saxony |
| Audax Private Equity | Boston, Massachusetts, United States |
| CA Capital | California, Sacramento, United States |
| Capital Access Holdings | - |
| Deep Space Ventures | Dallas, Texas, United States |
| DPI Energy Ventures | - |
| Easter Egg | Italy, Lombardy, Milan |
| GoldPoint Partners | New York, New York, United States |
| ISEP Business Angels | France, Ile-de-France, Paris |
| KB 1 Capital India | - |
| Monsas Investment Bank | England, London, United Kingdom |
| National Geographic Ventures | District of Columbia, United States, Washington |
| Pix Vine Capital | Central, Central Region, Singapore |
| Sherbrooke Innopole | Canada, Quebec, Sherbrooke |
| Stonehenge Investments | - |
| Suprema | - |
| Tap4Fun | Chengdu, China, Sichuan |
| Yingdu Wentou | Beijing, Beijing, China |
| Zhejiang Collaborative Innovation North Investment Management Ltd. | China, Hangzhou, Zhejiang |
| ZyQuest Inc. Technology and Development | De Pere, United States, Wisconsin |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Neurotype Inc. | $326K | 01 Jul 2023 | Minneapolis, Minnesota, United States | ||
Neurotype Inc. | $5K | 15 Nov 2022 | Minneapolis, Minnesota, United States | ||
Neurotype Inc. | $350K | 15 Sep 2020 | Minneapolis, Minnesota, United States | ||
Neurotype Inc. | $10K | 13 Jun 2019 | Minneapolis, Minnesota, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Neurotype Inc. | $326K | 01 Jul 2023 | Minneapolis, Minnesota, United States | ||
Neurotype Inc. | $5K | 15 Nov 2022 | Minneapolis, Minnesota, United States | ||
Neurotype Inc. | $350K | 15 Sep 2020 | Minneapolis, Minnesota, United States | ||
Neurotype Inc. | $10K | 13 Jun 2019 | Minneapolis, Minnesota, United States |
